No Detail Found!

Role of SLC44A3-AS1 Enhancer RNA in Esophageal Cancer Prognosis

Author(s)
Kai Kang Department of Thoracic Surgery, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, China
Jingyi Wu Department of Thoracic Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, China
Yajun Mao Operating Room, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China
Jindan Kai Department of Thoracic Surgery, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, China
Si Chen Department of Thoracic Surgery, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology,Hubei, China
Fei Xiong Department of Thoracic Surgery, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, China
Abstract
Objective: To identify key enhancer RNAs (eRNA) in esophageal cancer through a comprehensive analysis and explore its importance in esophageal cancer. Study Design: An observational study. Place and Duration of the StudyD:epartment of Thoracic Surgery, Hubei Cancer Hospital a liated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China, from September to October 2022. Methodology: RNA-sequencing data, survival data, and clinical data for a total of 33 tumours were gathered from TCGA (The Cancer Genome Atlas) datasets. The survival-associated eRNAs were detected by means of Spearman's correlation and Kaplan-Meier survival analyses. Enhancer RNAs linked to survival rate and their target genes in esophageal cancer were screened, and a clinical correlation analysis of key eRNAs was carried out. A functional enrichment analysiswas performed and the selected key eRNAs were con rmed in pan-cancer. Results: The key eRNA was identi ed asSLC44A3-AS1, and patients with higher expression ofSLC44A3-AS1 had worse prognosis than those with low expression. SLC44A3-AS1 expression was signi cantly associated with many clinical traits, namely tumour status, grade, pathological tumour, node, metastasis (TNM) stage, tumour type, etc. According to KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway enrichment results,SLC44A3 may a ect the prognosis of esophageal cancer patients through the herpes simplex virus 1 (HSV1) infection pathway. According to pan-cancer validation results, SLC44A3-AS1 was related to the survival of eight tumours. Correlations were observed between SLC44A3-AS1 and SLC44A3 in 32 types of tumours. Conclusion: SLC44A3-AS1 plays a key role in esophageal cancer related to prognosis, which may be a new therapeutic target for clinical exploration.
Publication Details
Page(s) 964-971
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 33, Issue: 9, Year: 2023

Request the full text from PASTIC

Keywords
prognosis, Esophageal cancer, Enhancer RNA, SLC44A3-AS1
0

Citations

0

Downloads

40

Views